Pharmac South 2024

Pharmac South 2024

24.05.2024 - 25.05.2024 Chennai, India, Chennai Trade Center (CTC)
Tickets Hotels near Hotels near
Visit the official Organizer website to ensure the accuracy of the event
Category: Medical & Pharma, Pharmaceuticals
Organizer: Orbit Exhibitions Pvt. Ltd.
Exhibition center: Chennai Trade Center (CTC)

Overview interest facts - Pharmac South 2024

PHARMAC SOUTH 2024 - 9th Edition stands out as a leading Pharmaceutical, Nutraceutical & Contract Manufacturing, Exhibition & Conference, attracting participants ranging from manufacturers to trade professionals across various sectors including Pharma Machinery, Analytical Instruments, Lab Equipment, Herbal, and Cosmetics. Regarded as a cornerstone event for the pharmaceutical and allied industries, it offers a valuable platform for gaining insights into industry trends, engaging with key technical and regulatory figures, and fostering dialogue with associated stakeholders.

Attendees benefit from the opportunity to network and exchange perspectives with prominent suppliers of pharmaceutical products and services, making PHARMAC SOUTH an essential event for industry professionals.

Overview of exhibitors / visitors - Pharmac South 2024

Contract Manufacturers, Contract Research Organizations (CROS), Nutraceutical Product/ Dietary Supplements, Ayurvedic / Herbal Products, Pharmaceutical Machinery, Pharmaceutical Formulation & Apl's, Pharmaceutical Bulk Drugs, Veterinary Drugs, Additives, Intermediates, Pharmaceutical Printing & Packaging, Pharma Ancillary & Utility Services & Maintenance, Software For Pharmaceutical Industry & Management, Bio-pharmaceuticals/ Bio Lab Instruments & Equipment, Pharmaceutical Engineering/Refrigeration, Clean Room Technology, Analytical Laboratory Supplies (instruments, Glassware, Lab Reagents -chemicals), Banks/ Financial Sectors Focusing On Pharma Industry, Trade Promotion Bodies -technical Publications/ Trade Associations/ Media/ Publications, Patent/ Trade Mark Lawyers.


​AstraZeneca adds to rare blood disease portfolio with world-first Voydeya approval in Japan

A month after Novartis made its entry into the paroxysmal nocturnal haemoglobinuria (PNH) field, AstraZeneca’s newest contender Voydeya bolsters the company’s presence...

22 January 2024
​New material improves treatment of complex bone infections

Researchers in Ireland have combined antimicrobial implants and gene therapies to develop a new surgical solution with the potential to improve the treatment of comple...

29 November 2023
Sepsis - as common as cancer, as deadly as a heart attack

In 2016, the research team conducted an initial study in southern Sweden (Skåne) where they revealed that sepsis is much more common than previously believed.

04 September 2023
​FDA approves first oral treatment for postpartum depression

Following the approval, Biogen plans for the commercial launch Zurzuvae (zuranolone) in Q4 2023.

10 August 2023
​New blood test finds two thirds of cancers

A new multi-cancer early detection blood test could speed up diagnosis.

16 June 2023
​EU Proposes Drug Manufacturing Overhaul, Faces Pushback

The European Union on April 26 has released a draft of the probable and proposed revamp of its drug manufacturing laws

04 May 2023
All news